Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Volumetric Response and Survival of Patients With Bulky IDH-Mutated Grade 3 Glioma Managed With FET-FDG-Guided Integrated Boost IMRT.

Clinical oncology (Royal College of Radiologists (Great Britain)) - 1 Jun 2024

Mills D, Horsley P, Venkatasha V, Back M

Abstract excerpt

AIMS: Despite relatively favourable outcomes associated with IDH-mutant grade 3 gliomas, many patients present with diffuse non-enhancing disease involving multiple brain regions, prompting concern over both durable disease control and the morbidity associated with large volume radiation therapy. This study audits volumetric response, survival and functional outcomes in this 'large volume' subgroup that undergoes...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Brain Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Fluorodeoxyglucose F18

Share to Glioma

Share to Isocitrate Dehydrogenase

Share to Mutation

Share to Neoplasm Grading

Share to Radiopharmaceuticals

Source

Identifiers

PMID: 38553362
DOI: 10.1016/j.clon.2024.03.002

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Volumetric Response and Survival of Patients With Bulky IDH-Mutated Grade 3 Glioma Managed With FET-FDG-Guided Integrated Boost IMRT.PMID 38553362Read ↗

Volumetric response and pattern of failure of histone altered high grade glioma in adults following management with radiation therapy.Semantic proximity Read ↗

ESTRO-EANO guideline on target delineation and radiotherapy for IDH-mutant WHO CNS grade 2 and 3 diffuse glioma.Semantic proximity Read ↗

Impact of Frontline Ivosidenib on Volumetric Growth Patterns in Isocitrate Dehydrogenase-mutant Astrocytic and Oligodendroglial Tumors.Semantic proximity Read ↗

Analysis of safety and efficacy of proton radiotherapy for IDH-mutated glioma WHO grade 2 and 3.Semantic proximity Read ↗

Survival, late toxicity and ability to return to work after proton radiotherapy for low grade gliomasSemantic proximity Read ↗

The Role of Extent of Resection in IDH1 Wild-Type or Mutant Low-Grade Gliomas.Semantic proximity Read ↗

Longitudinal analysis of cognitive function in patients treated with postoperative radiotherapy for grade 2 and 3 IDH mutant diffuse glioma.Semantic proximity Read ↗

Tumor Volume Growth Rates and Doubling Times during Active Surveillance of IDH-mutant Low-Grade Glioma.Semantic proximity Read ↗

Response assessment during chemoradiation using a hypercellular/hyperperfused imaging phenotype predicts survival in patients with newly diagnosed glioblastoma.Semantic proximity Read ↗

Neurocognitive functioning, seizure control, and return to work after awake surgery with or without adjuvant therapy in IDH-mutant grade 3 diffuse gliomas.Semantic proximity Read ↗

Increased sensitivity to radiochemotherapy in IDH1 mutant glioblastoma as demonstrated by serial quantitative MR volumetry.Semantic proximity Read ↗

Increased Radiation-Associated T-Cell Infiltration in Recurrent IDH-Mutant Glioma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.